Global Cancer Pain Therapeutics Market 2015-2019

  • ID: 3608957
  • Report
  • Region: Global
  • 61 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • BioDelivery Sciences
  • Eli-lilly
  • Grunenthal Group
  • Hospira
  • Meda Pharmaceuticals
  • ProStrakan Group
  • MORE
About Cancer Pain Therapeutics

Cancer pain can be acute or chronic, depending on its stages and types. Cancer pain is caused by the tumor pressing against bones, nerves, or other organs in an individual's body. Pain control is imperative not only for people who have advanced cancer but also for those whose condition remains stable for years. Pharmaceutical interventions such as non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and adjuvant pain medications are used to treat cancer pain.

The analysts forecast the global cancer pain therapeutics market to grow at a CAGR of 9.08% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global cancer pain therapeutics market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of cancer pain.
The market is divided into the following segments based on region:
- Americas: The US, Canada, Mexico, and Brazil
- EMEA: The UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
- APAC: Japan, China, Australia, Singapore, South Korea, and India

The report, Global Cancer Pain Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- BioDelivery Sciences
- ProStrakan Group
- Teva Pharmaceuticals
- Yamaha

Other prominent vendors
- Daiichi Sankyo
- Eli-lilly
- Galena Biopharma
- Grunenthal Group
- GW Pharmaceuticals
- Hospira
- Johnson & Johnson
- Meda Pharmaceuticals
- Orexo
- Sanofi
- Sorrento Therapeutics
- WEX Pharmaceuticals

Market drivers
- Unmet medical needs
- For a full, detailed list, view the full report

Market challenges
- Off-label drug use
- For a full, detailed list, view the full report

Market trends
- Increase in awareness
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • BioDelivery Sciences
  • Eli-lilly
  • Grunenthal Group
  • Hospira
  • Meda Pharmaceuticals
  • ProStrakan Group
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Disease overview
  • Understanding the disease
  • Signs and symptoms
  • Causes of cancer pain
  • Assessment of cancer pain
  • Treatment
  • Epidemiology
PART 06: Pipeline portfolio
  • Information on pipeline candidates
PART 07: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 08: Market segmentation by drug class
  • Opioids
  • Non-steroidal anti-inflammatory drugs
  • Others
PART 09: Geographical segmentation
  • Cancer pain therapeutics market in Americas
  • Cancer pain therapeutics market in EMEA
  • Cancer pain therapeutics market in APAC
PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape
  • Competitive scenario
  • Market analysis 2014
PART 16: Vendor landscape
  • Other prominent vendors
PART 17: Key vendor analysis
  • BioDelivery Sciences
  • ProStrakan
  • Teva Pharmaceuticals
PART 18: Appendix
  • List of abbreviations
PART 19: About the Author

Exhibit 01: Product offerings
Exhibit 02: Classification of cancer pain
Exhibit 03: Acute pain syndromes
Exhibit 04: Chronic pain syndromes
Exhibit 05: Causes of pain from cancer
Exhibit 06: Causes of pain from procedures and surgery
Exhibit 07: Causes of pain from other cancer treatments
Exhibit 08: Common causes of pain in cancer patients
Exhibit 09: Cancer pain assessment
Exhibit 10: Types of pain scales
Exhibit 11: Treatment options for cancer pain
Exhibit 12: Commonly used non-opioids for pain management
Exhibit 13: Commonly used adjuvant medicines for cancer pain
Exhibit 14: Management of cancer pain
Exhibit 15: Pipeline molecules for cancer pain therapeutics market
Exhibit 16: Global cancer pain therapeutics market ($ millions)
Exhibit 17: Five forces analysis
Exhibit 18: Global cancer pain therapeutics market by drug class
Exhibit 19: Global cancer pain therapeutics market by geographical segmentation 2014
Exhibit 20: Cancer pain therapeutics market in different regions, 2014-2019 ($ millions)
Exhibit 21: Cancer pain therapeutics market in the Americas 2014-2019 ($ millions)
Exhibit 22: Cancer pain therapeutics market in EMEA 2014-2019 ($ millions)
Exhibit 23: Cancer pain therapeutics market in APAC 2014-2019 ($ millions)
Exhibit 24: Impact of drivers
Exhibit 25: Impact of drivers and challenges
Exhibit 26: BioDelivery Sciences: Key takeaways
Exhibit 27: ProStrakan: Key takeaways
Exhibit 28: Teva Pharmaceuticals: Key takeaways
Exhibit 29: BioDelivery Sciences: Product pipeline
Exhibit 30: Teva Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 31: Teva Pharmaceuticals: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 32: Teva Pharmaceuticals: Geographical segmentation by revenue 2014
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • BioDelivery Sciences
  • Eli-lilly
  • Grunenthal Group
  • Hospira
  • Meda Pharmaceuticals
  • ProStrakan Group
  • MORE
New Report Released: – Global Cancer Pain Therapeutics Market 2015-2019

The author of the report recognizes the following companies as the key players in the Global Cancer Pain Therapeutics Market: BioDelivery Sciences, ProStrakan Group and Teva Pharmaceuticals

Other Prominent Vendors in the market are: Daiichi Sankyo, Eli-lilly, Galena Biopharma, Grunenthal Group, GW Pharmaceuticals, Hospira, Johnson & Johnson, Meda Pharmaceuticals, Orexo, Sanofi, Sorrento Therapeutics, and WEX Pharmaceuticals.

Commenting on the report, an analyst from the research team said: “At present, the cancer pain therapeutics market has Teva Pharmaceuticals, BioDelivery Sciences, and ProStrakan Group as the key players. Teva Pharmaceutical's Actiq and Fentora; and ProStrakan's Abstral and Lazanda compete directly with BioDelivery Sciences' Onsolis. To overcome the severe competition being posed, the key players and other vendors have started differentiating their drugs in an attempt to increase profits and avoid price competition.”

According to the report, the major driving factor for the global cancer pain therapeutics market is the high unmet need for appropriate drugs in the market.

Further, the report states that the use of off-label drugs is another important challenge for the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- BioDelivery Sciences
- ProStrakan Group
- Teva Pharmaceuticals
- Daiichi Sankyo
- Eli-lilly
- Galena Biopharma
- Grunenthal Group
- GW Pharmaceuticals
- Hospira
- Johnson & Johnson
- Meda Pharmaceuticals
- Orexo
- Sanofi
- Sorrento Therapeutics
- WEX Pharmaceuticals.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll